Item 9 Labs Corp. — Cyborg Score 4/10

Mixed
Cannabis

Strategic Profile

The company is a vertically integrated cannabis operator delivering premium products from large-scale cultivation and production facilities, while offering a dispensary franchise model through Unity Rd that provides resources and support for dispensary owners to operate compliant retail locations. The company faced operational challenges with a court-appointed receiver in July 2023, though it implemented restructuring efforts to reduce costs and explore strategic alternatives.

Cyborg Score Rationale

Item 9 Labs operates in a growing cannabis market with branded products and a franchise model, but faces significant financial and operational headwinds including a receivership appointment in July 2023, accumulated losses, and exploration of sale alternatives. The company's strategic assets—cultivation capabilities and brand recognition—are offset by regulatory and capital constraints.

Top Insights

  • Vertically integrated model spanning cultivation, production, and retail franchising provides control over supply chain and brand consistency
  • Company appointed a court receiver in July 2023, signaling severe financial distress
  • Achieved $400 thousand of positive Adjusted EBITDA in fiscal Q2 2023 and implemented $3.5+ million in annual cost reductions
  • Dual business model targets both direct cannabis product sales and franchise licensing revenue through Unity Rd national retail brand

Named Competitors

  • Flower/Concentrates/Distillates — Multi-category cannabis products and retail
  • Cannabis retail dispensary — Multi-state cannabis retail and cultivation
  • Cannabis cultivation and retail — Large-scale cannabis retailer

Recent Developments

  • (July 2023) Court-appointed receiver Resolute Commercial Services assumed control of operations
  • (May 2023) Major restructuring executed with CEO change; Doug Bowden named Interim CEO; announced $3.5M+ annual cost reduction program
  • (March 2022) Merger/acquisition with The Herbal Cure completed

Open the full interactive Item 9 Labs Corp. report

Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.

Open report →